drugset / Trial / NCT00004804
Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C
Phase 3
Completed
57 enrolled
National Center for Research Resources (NCRR)
Tulane University School of Medicine · collab
Treatment
Summary
OBJECTIVES: I. Determine whether the initial response to interferon alfa (IFN-A) can be increased by starting at a dose of 5 MU three times a week in patients with chronic hepatitis C. II. Determine whether patients who had normalized alanine aminotransferase (ALT) levels can maintain normal ALT during stepwise dose reduction from 5 MU to 3 MU to 1.5 MU.
Timeline
- Start
- 1993-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interferon alfa | Protein / enzyme biologic | 5e+06 iu | Subcutaneous |